In recent years, non-communicable diseases (NCDs) have accounted for about 70% of the world's deaths. The most common NCDs are cardiovascular disease, cancer, diabetes mellitus, and chronic respiratory diseases. These diseases have four common risk factors, including inadequate physical activity, unhealthy diet, smoking, and excessive alcohol consumption. Cardiovascular diseases, despite their high prevalence, are the most preventable chronic diseases. The most common risk factor for cardiovascular disease is high blood pressure, which can be prevented if it is diagnosed and controlled carefully. Recent guidelines have changed the methods of blood pressure measurement, definition, and treatments. Recently, more emphasis has been placed on Out-of-Office Blood Pressure Measurement. Therefore, it is necessary to consider the methods of measuring blood pressure at home and 24-hour Holter blood pressure monitoring, as well as understanding its standards. The use of automatic arm sphygmomanometers to measure blood pressure is more acceptable than manual ones (mercury or Aneroid). The most accepted definitions of hypertension are BP≥140/90 mm Hg in the clinic, the average blood pressure at home≥135/85 mm Hg, and the average blood pressure in 24-hour Holter monitoring≥130/80 mm Hg. Proper treatment of hypertension by changing lifestyle and proper medication therapy can control blood pressure and prevent serious complications. Today, the use of combination drugs, especially a single pill in a single dose, has been emphasized. This study aimed to review the most recent hypertension treatment protocols based on the guidelines of the American Heart Association (AHA 2017), the European Society of Cardiology (ESC 2018), the British Heart Association (NICE 2019), and the International Society of Hypertension (ISH 2020). Furthermore, this study attempted to assess the symptoms, complications, methods of diagnosing, definitions, as well as pharmacological and non-pharmacological treatments of hypertension.

 


1- Rezaianzadeh A, Jafari F, Sadeghi SE, Rahimikazerooni S. The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran. J Hum Hypertens. 2021; 35(3): 257-264. DOI: 10.1038/s41371-020-0330-8.
2- Panahi MH, Mahdavi Hezaveh AR, Samavat T, Hodjatzadeh A, Yousefi E. Hypertension Surveillance in Rural Regions of Iran. Iran J Public Health. 2019; 48(12): 2313-4. Link
3- Kazemi T, Nik M. “World heart day 2014”, Significance of cardiovascular diseases in east of Iran. J Res Med Sci. 2015; 20(5): 423 . DOI: 10.4103/1735-1995.163950
4- Kazemi T, Hajihosseini M, Mashreghimoghadam H, Azdaki N, Ziaee M. Prevalence and determinants of hypertension among Iranian adults, Birjand, Iran. Int J Prev Med. 2017; 8:36. DOI: 10.4103/ijpvm.IJPVM_103_16
5- Kazemi T, Tavakoli T, Hajihosseini M, Yari E. Prevalence of Pre-hypertension and Risk Factors in an Iranian Population: East of Iran. Int Cardio Res J. 2018; 12(1):e10335. Link
6- Azdaki N, Kazemi T. National project of blood pressure control: Do's and don't's.J Birjand Univ Med Sci. 2019; 26(2): 95-7. DOI: 10.32592/JBirjandUnivMedSci.2019.26.2.100
7- Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71(6): 1269-1324. DOI: 10.1161/HYP.0000000000000066
8- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). J Hypertens. 2018; 36(10): 1953-2041. DOI: 10.1097/HJH.0000000000001940
9- Bakris G, Ali W, Parati G. ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison. J Am Coll Cardiol. 2019; 73(23): 3018-26. DOI: 10.1016/j.jacc.2019.03.507
10- Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020; 75(6): 1334-57. DOI: 10.1161/HYPERTENSIONAHA.120.15026
11- Freeman R, Illigens BM, Lapusca R, Campagnolo M, Abuzinadah AR, Bonyhay I, et al. Symptom Recognition Is Impaired in Patients With Orthostatic Hypotension. Hypertension. 2020; 75(5): 1325-32. DOI: 10.1161/HYPERTENSIONAHA.119.13619
12- Song BM, Kim HC, Shim J-S, Kang DR. Comparison between right and left upper arms in detection of hypertension. Korean Circ J. 2019; 49(3): 267-77. DOI: 10.4070/kcj.2018.0147
13- Muntner P, Einhorn PT, Cushman WC, Whelton PK, Bello NA, Drawz PE, et al. Blood pressure assessment in adults in clinical practice and clinic-based research: JACC scientific expert panel. J Am Coll Cardiol. 2019; 73(3): 317-35. DOI: 10.1016/j.jacc.2018.10.069
14- Etyang AO, Sigilai A, Odipo E, Oyando R, Ong’ayo G, Muthami L, et al. Diagnostic accuracy of unattended automated office blood pressure measurement in screening for hypertension in Kenya. Hypertension. 2019;74(6):1490-98. DOI: 10.1161/HYPERTENSIONAHA.119.13574
15- Victor RG, Li N, Blyler CA, Mason ONR, Chang LC, Moy NPB, et al. Nocturia as an unrecognized symptom of uncontrolled hypertension in black men aged 35 to 49 years. J Am Heart Assoc. 2019; 8(5): e010794. DOI: 10.1161/JAHA.118.010794
16- Goldmann E, Roberts ET, Boden-Albala B. Abstract P190: Hypertension, Hypertension Awareness and Depressive Symptom Severity in a Large Hispanic Population. Circulation. 2017; 135(suppl_1): AP18. DOI: 10.1161/circ.135.suppl_1.p189
17- Krause I, Cleper R, Kovalski Y, Sinai L, Davidovits M. Changes in behavior as an early symptom of renovascular hypertension in children. Pediatr Nephrol. 2009; 24(11): 2271-4. DOI: 10.1007/s00467-009-1205-y
18- Naseh G, Fard MM, Kazemi T, Mirgholami A, Hashemi N, Saburi A. Comparison of carotid intima-media thickness in hypertensive patients and control group. J Cardiovasc Echogr. 2016; 26(2): 48-51. DOI: 10.4103/2211-4122.183749
19- Takasaki K, Miyata M, Imamura M, Yuasa T, Kuwahara E, Kubota K, et al. Left ventricular dysfunction assessed by cardiac time interval analysis among different geometric patterns in untreated hypertension. Circ J. 2012; 76(6): 1409-14. DOI: 10.1253/circj.cj-11-1369
20- Jones NR, McCormack T, Constanti M, McManus RJ. Diagnosis and management of hypertension in adults: NICE guideline update 2019. Br J Gen Pract. 2020 Feb 1;70(691):90-1. DOI: 10.3399/bjgp20X708053
21- Tang S, Brady M, Mildenhall J, Rolfe U, Bowles A, Morgan K. The new coronavirus disease: what do we know so far? Journal of Paramedic Practice (JPP). 2020; 12(5): 193-201. DOI: 10.12968/jpar.2020.12.5.193
22- Kai H, Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19. Hypertens Res. 2020; 43, 648–654. DOI: 10.1038/s41440-020-0455-8
23- Cardiology ESo. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. ESC. 2020.
24- Ren L, Yu S, Xu W, Overton JL, Chiamvimonvat N, Thai PN. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: a meta-analysis. J Cardiol. 2021; 77(5): 482-91. DOI: 10.1016/j.jjcc.2020.10.015
25- Du Y, Zhou N, Zha W, Lv Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr Metab Cardiovasc Dis. 2021; 31(3): 745-55. DOI: 10.1016/j.numecd.2020.12.009
26- Sheppard JP, Nicholson BD, Lee J, McGagh D, Sherlock J, Koshiaris C, et al. Association between blood pressure control and coronavirus disease 2019 outcomes in 45 418 symptomatic patients with hypertension: an observational cohort study. Hypertension. 2021; 77(3): 846-55. DOI: 10.1161/HYPERTENSIONAHA.120.16472